Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,206,947 papers from all fields of science
Search
Sign In
Create Free Account
Antisense Technology
The use of nucleic acid oligomers to bind to a specific mRNA to deter protein production.
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
LIPID METABOLISM CORRECTION BY ANTISENSE TECHNOLOGY
O. Afanasieva
,
S. Pokrovsky
2013
Corpus ID: 74603872
Antisense oligonucleotides (ASO) technology in elaboration of drugs for lipid metabolism correction is discussed. The main ASO…
Expand
Review
2011
Review
2011
Making sense of therapeutics using antisense technology
R. Malik
,
I. Roy
Expert Opinion on Drug Discovery
2011
Corpus ID: 22666721
Introduction: Antisense oligonucleotides (ASOs) are short synthetic single-stranded DNA sequences that bind to and induce the…
Expand
Review
2010
Review
2010
siRNA: Sojourn from discovery to delivery challenges and clinics
S. Trehan
,
G. Sharma
,
A. Misra
2010
Corpus ID: 20910759
Since the Nobel prize-winning discovery of RNA interference (RNAi) in 1998, considerable money has been invested in the…
Expand
2010
2010
Bt brinjal splits Indian cabinet
K. Jayaraman
Nature Biotechnology
2010
Corpus ID: 30446363
volume 28 number 4 april 2010 nature biotechnology The news was not all positive, however. Elevated liver enzymes were observed…
Expand
2008
2008
Evaluation of cystine transport in cultured human kidney cells and establishment of cystinuria type I phenotype by antisense technology
G. Wendt‐Nordahl
,
S. Sagi
,
C. Bolenz
,
P. Alken
,
M. Michel
,
T. Knoll
Urological research
2008
Corpus ID: 22747914
Cystinuria is a rare hereditary disease resulting in recurrent stone formation and the need for repeated invasive interventions…
Expand
Review
2003
Review
2003
Antisense DNAs as targeted genetic medicine to treat cancer
Y. Cho‐Chung
Archives of pharmacal research
2003
Corpus ID: 22018788
Nucleic acid therapies represent a direct genetic approach for cancer treatment. Such an approach takes advantage of mechanisms…
Expand
Review
2001
Review
2001
Redirection of drug metabolism using antisense technology.
Arora
,
Patrick L. Iversen
Current opinion in molecular therapeutics (Print)
2001
Corpus ID: 25650405
The cytochrome P450 (CYP) family is the most catalytically versatile component of the phase I oxidation metabolic pathway and…
Expand
2000
2000
Gene switching: analyzing a broad range of mutations using steric block antisense oligonucleotides.
P. Morcos
Methods in Enzymology
2000
Corpus ID: 32586883
Review
1999
Review
1999
Conformationally restricted carbohydrate-modified nucleic acids and antisense technology.
P. Herdewijn
Biochimica et Biophysica Acta
1999
Corpus ID: 8070247
1997
1997
Antisense S-oligodeoxynucleotides down-regulate TGFbeta-production by Kupffer cells from CCl4-injured rat livers.
Juan Armendáriz-Borunda
,
Leighton LeGros
,
Octavio Campollo
,
Arturo Panduro
,
A. R. Rincón
Biochimica et Biophysica Acta
1997
Corpus ID: 18347360
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE